-
-
-
-
-
-
-
DeepHealth wins FDA clearance for AI breast ultrasound tool
-
-
-
-
-
-
-
Cingulate publishes phase 3 ADHD drug trial results in peer-reviewed journal
-
-
-
-
-
-
-
Pfizer's Litfulo meets Phase 3 goals in vitiligo skin condition
-
-
-
-
-
-
-
FDA grants RMAT and fast track status to Allogene's cema-cel
-
-
-
-
-
-
-
Silexion activates first Phase 2/3 trial site for SIL204 in Israel
-
-
-
-
-
-
-
Trump administration to end Medicare drug plan subsidy after 2026 - WSJ
-
-
-
-
-
-
-
Dasher Neuroscience finishes enrollment in Phase 2 MSA drug trial
-
76,543 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.

